J. Goldman & Co’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.33M | Buy |
|
|||||
|
2025
Q1 | $1.69M | Buy |
|
|||||
|
2024
Q4 | $424K | Sell |
|
|||||
|
2024
Q3 | $1.16M | Sell |
|
|||||
|
2024
Q2 | $2.46M | Buy |
|
|||||
|
2024
Q1 | – | Hold |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $1.68M | Buy |
|
|||||
|
2023
Q2 | $474K | Sell |
|
|||||
|
2023
Q1 | $1.66M | Buy |
|
|||||
|
2022
Q4 | $532K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $1.56M | Sell |
|
|||||
|
2020
Q3 | $2.06M | Sell |
|
|||||
|
2020
Q2 | $5.23M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $631K | Sell |
|
|||||
|
2017
Q3 | $4.11M | Sell |
|
|||||
|
2017
Q2 | $7.35M | Sell |
|
|||||
|
2017
Q1 | $9.65M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $10.2M | Sell |
|
|||||
|
2016
Q2 | $13.9M | Buy |
|
|||||
|
2016
Q1 | $12.3M | Buy |
|
|||||
|
2015
Q4 | $7.61M | Buy |
|
|||||
|
2015
Q3 | $6.73M | Buy |
|
|||||
|
2015
Q2 | $602K | Buy |
|
|||||
|
2015
Q1 | $450K | Sell |
|
|||||
|
2014
Q4 | $1.77M | Buy |
|